; (2) actions that the Director of the National Institute of Neurological Disorders and Stroke to address such challenges; and (3) any legislative recommendations (including requests for appropriations) to further improve the administration of such clinical trials. 5. Effective date The amendments made by this Act shall take effect on the date of the enactment of this Act.